Filtered By:
Specialty: Drugs & Pharmacology
Infectious Disease: COVID-19
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 161 results found since Jan 2013.
Impact of COVID-19 pandemic lockdown on occupational therapy practice and use of telerehabilitation - A cross sectional study
CONCLUSIONS: The COVID-19 pandemic lockdown experiences made us rethink the current approach of therapy services into alternative method (mixed mode) delivery of occupational therapy practice, which is including the combined method of video-based (telerehabilitation) consultation and face to face intervention.PMID:34002837 | DOI:10.26355/eurrev_202105_25845
Source: European Review for Medical and Pharmacological Sciences - May 18, 2021 Category: Drugs & Pharmacology Authors: B Ganesan K N K Fong S K Meena P Prasad R K Y Tong Source Type: research
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19-induced Damage to the Nervous System
Curr Neuropharmacol. 2021 Apr 8. doi: 10.2174/1570159X19666210408123807. Online ahead of print.ABSTRACTThe edible cyanobacterium Spirulina platensis and its chief biliprotein C-Phycocyanin have shown protective activity in animal models of diverse human health diseases, often reflecting antioxidant and anti-inflammatory effects. The beneficial effects of C-Phycocyanin seem likely to be primarily attributable to its covalently attached chromophore Phycocyanobilin (PCB). Within cells, biliverdin is generated from free heme and it is subsequently reduced to bilirubin. Although bilirubin can function as an oxidant scavenger, i...
Source: Current Neuropharmacology - April 8, 2021 Category: Drugs & Pharmacology Authors: Giselle Pent ón-Rol Javier Mar ín-Prida Mark F McCarty Source Type: research
